NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)
Leeds Teaching Hospitals NHS Trust
- Value
- £43,314,823.84
- Published
- 23 Sept 2026
- Deadline
- Not stated
- Procedure
- Not stated
- Category
- 33600000 — Pharmaceutical products
- Location
- Leeds, UKE42, LS1 3EX, United Kingdom
- Notice reference
- 090112-2026
Requirements summary
Leeds Teaching Hospitals NHS Trust is planning to establish a framework agreement for the supply of unlicensed imported medicines to NHS organizations and other public sector bodies. This framework aims to provide safe, compliant, and quality-assured access to these medicines for patients whose clinical needs cannot be met by licensed alternatives.
Key requirements
- Suppliers must provide a defined range of unlicensed imported medicines, including those requiring over-labelling and translation.
- All suppliers must hold relevant MHRA licences for importing, distributing, and supplying unlicensed medicines in the UK.
- Compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards is required.
- The contract period will commence from May 1, 2027, until December 31, 2028, with potential for renewal.
- The procurement is anticipated to be valued at GBP 43,314,823.84.